Table 1. Patient demographics.
Female | Male | Total | |
---|---|---|---|
No. of patients | 50 | 52 | 102 |
Age (median (range)) | 74.4 (42–93) | 70.3 (43–87) | 72.3 |
Dukes's stage | |||
A | 4 (8%) | 12 (22.2%) | 16 (15.7%) |
B | 22 (44%) | 16 (30.8%) | 40 (37.2%) |
C | 24 (48%) | 24 (44.4%) | 48 (47.0%) |
D | 0 | 0 | 0 |
TNM stage | |||
I | |||
T1N0MX | 2 (4%) | 4 (7.4%) | 6 (5.9%) |
T2N0MX | 3 (6%) | 8 (14.8%) | 12 (11.8%) |
II | |||
T3N0MX | 17 (34%) | 14 (26.9%) | 31 (30.4%) |
T4N0MX | 5 (10%) | 2 (3.7%) | 7 (6.9%) |
III | |||
T2N1MX | 0 | 1 (1.9%) | 1 (0.99%) |
T3N1MX | 6 (2%) | 11 (20.3%) | 17 (16.7%) |
T3N2MX | 10 (20%) | 7 (12.9%) | 17 (16.7%) |
T4N1MX | 4 (8%) | 3 (5.6%) | 7 (6.9%) |
T4N2MX | 3 (6%) | 2 (3.7%) | 5 (4.9%) |
Tumour localization | |||
Colon | 37 (74.0%) | 35 (67.3%) | 72 (70.6%) |
Rectum | 14 (26%) | 17 (32.7%) | 29 (29.4%) |
Differentiation | |||
Moderate | 39 (78.0%) | 48 (88.5%) | 87 (83.3%) |
Poor | 11 (22.0%) | 6 (11.5%) | 17 (16.7%) |
Abbreviation: TNM=tumour, node, metastasis;